We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Anandamide as a Marker of Human Disease—Reply

Osama M. H. Habayeb, MBBS; Anthony H. Taylor, PhD; Justin C. Konje, MD
JAMA. 2008;300(3):281-282. doi:10.1001/jama.2008.27.
Text Size: A A A
Published online


In Reply: Dr Maccarrone highlights the complexity of the endocannabinoid system and the potential implications of aberrations in this system with regard to human physiology. We agree that an increased understanding of the role of endocannabinoids in physiology and pathology may help in the development of new diagnostic and therapeutic approaches, not only in reproduction but in other systems.

The endocannabinoid system appears to produce a biphasic behavioral pattern in most physiological and pathological states in which it has been studied.1 The current understanding of the precise regulation of this biphasic pattern or its significance is limited. Our data support the findings of Maccarrone et al,2 but these are only early observations. The women in our studies were healthy, and none of them had any of the disorders mentioned by Maccarrone. We endorse the call to undertake more research in this area to understand how this system is involved not only in the regulation of reproduction but in the other pathological states mentioned in his letter.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




July 16, 2008
Mauro Maccarrone, PhD
JAMA. 2008;300(3):281-282. doi:10.1001/jama.2008.26.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.